Release Date: 17/10/14 15:17 Summary: Activity Report & Appendix 4C Price Sensitive: Yes Download Document 153.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%